전립선암에서 골전이 진단에 대한 F-18 FDG PET/CT와 골스캔의 불일치 (Discrepancy of Bone Metastases between F-18 FDG PET/CT and Bone Scan in a Patient with Prostate Cancer) |
Author |
최승진1,김철수2,변성수3,현인영1, |
Seung Jin Choi, M.D.1, Chul Soo Kim, M.D.2, Sung Su Byun, M.D.3 and In Young Hyun, M.D.1 |
Affiliation |
인하대학교 의과대학 핵의학교실1, 내과학교실2, 방사선과학교실3 Department of 1Nuclear Medicine, 2Internal Medicine, and 3Radiology, Inha University College of Medicine, Incheon, Korea |
Abstract |
We report the case of a 73-year-old man who had prostate cancer with bone metastases. Tc-99m HDP Whole
body bone scan revealed multiple areas of increased bony uptake consistent with widespread bone metastases.
F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated mild
F-18 FDG uptake in the lymph nodes of neck, abdomen, and pelvis. However, abnormal F-18 FDG uptake was not
seen in the skeletal system. Biopsy and immunohistochemical stains of left supraclavicular mass showed metastatic
prostate adenocarcinoma. Currently, there are a few reported cases of F-18 FDG PET/CT evaluation of bone
metastases in prostate cancer. We discuss the discrepancy between F-18 FDG PET/CT and bone scan in the
detection of osseous metastases of prostate cancer. (Nucl Med Mol Imaging 2006;40(5):275-278)
|
Keyword |
osseous metastases, bone scan, F-18 FDG PET/CT, prostate cancer |
Full text Article |
4005275.pdf
|
|
|